MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

BR 37/2001

1972 : 159

MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

The Minister of Health and Family Services, in exercise of the powers conferred on him by section 3(2) of the Misuse Of Drugs Act 1972, makes the following Order:⎯

Citation

1 This Order may be cited as the Misuse Of Drugs (Controlled Drugs) Order 2001.

Amendment of Schedule 2 to Act No. 159 of 1972

2 Part I of Schedule 2 to the Misuse of Drugs Act 1972 is deleted and the new Part I set forth in the Schedule to this Order is substituted.

Commencement

3 This Order commences on 1st August, 2001.

SCHEDULE 2 (paragraph 2)

PART I

1. The following substances and products, namely:-

(a) ACETORPHINE ACETYLDIHYDROCODEINE ALFENTANIL ALLYLPRODINE ALPHACETYLMETHADOL ALPHAMEPRODINE

1989 Revision 1 MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

ALPHAMETHADOL ALPHAPRODINE ALPRAZOLAM AMPHETAMINE ANILERIDINE ATAMESTANE

BENZETHIDINE BENZPHETAMINE BENZYLMORPHINE (3-Benzylmorphine) BETACETYLMETHADOL BETAMEPRODINE BETAMETHADOL BETAPRODINE BEZITRAMIDE BOLANDIOL BOLASTERONE BOLAZINE BOLDENONE BOLENOL BOLMANTALATE BROMAZEPAM BUFOTENINE BUPRENORPHINE

CALUUSTERONE CAMAZEPAM CANNABINOL DERIVATIVES CANNABINOL except where contained in Cannabis or Cannabis resin CANNABIS AND CANNABIS RESIN CARFENTANIL CATHINE CATHINONE CHLORDIAZEPOXIDE CHLORPHENTERMINE 4-CHLOROMETHANDIENONE CHORIONIC GONADOTROPHIN (HCG) and NON-HUMAN CHORIONIC GONADOTROPHIN CLENBUTEROL CLOBAZAM CLONAZEPAM CLONITAZENE CLORAZEPIC ACID CLOSTEBOL CLOTIAZEPAM CLOXAZOLAM COCA LEAF COCAINE

2 1989 Revision MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

CODEINE

DELORAZEPAM DESOMORPHINE DEXTROMORAMIDE DEXTROPROPOXYPHENE DIAMORPHINE DIAMPROMIDE DIAZEPAM DIETHYLPROPION DIETHYLTHIAMBUTENE DIFENOXIN (1-(3-cyano-3,3-diphenylpropyl)-4- phenylpiperidine-4-carboxylic acid) DIHYDROCODEINE DIHYDROCODEINONE O-CARBOXYMETHYLOXIME DIHYDROMORPHINE DIMENOXADOLE DIMEPHEPTANOL DIMETHYLTHIAMBUTENE DIOXAPHETYL BUTYRATE DIPHENOXYLATE DIPIPANONE DROSTANOLONE DROTEBANOL (3,4-dimethoxy-17-methylmorphinan- 6β,14-diol)

ECGONINE and any derivative of ecgonine which is convertible to ecgonine or to cocaine ENESTEBOL EPITIOSTANOL ESTAZOLAM ETHCHLORVYNOL ETHINAMATE ETHYL LOFLAZEPATE ETHYLMETHYLTHIAMBUTENE ETHYLMORPHINE (3-ethylmorphine) ETHYLOESTRENOL ETICYCLIDINE ETONITAZENE ETORPHINE ETOXERIDINE

FENCANFAMIN FENETHYLLINE FENPROPOREX FENTANYL FLUDIAZEPAM FLUNITRAZEPAM

1989 Revision 3 MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

FLUOXYMESTERONE FLURAZEPAM FORMEBOLONE FURAZABOL FURETHIDINE

GAMMA-BUTYROLACTONE GAMMA-HYDROXY-BUTYRATE GLUTETHIMIDE

HALAZEPAM HALOXAZOLAM HYDROCODONE HYDROMORPHINOL HYDROMORPHONE HYDROXYPETHIDINE

ISOMETHADONE

KETAMINE KETAZOLAM KETOBEMIDONE

LEFETAMINE LEVOMETHORPHAN LEVOMORAMIDE LEVOPHENACYLMORPHAN LEVORPHANOL LOFENTANIL LOPRAZOLAM LORAZEPAM LORMETAZEPAM LYSERGAMIDE LYSERGIDE and other N-alkyl derivatives of lysergamide

MAZINDOL MECLOQUALONE MEDAZEPAM MEDOLAZINE MEFENOREX MEPHENTERMINE MEPITIOSTANE MEPROBAMATE MESABOLONE MESCALINE MESTANOLONE MESTEROLONE METAZOCINE METHADONE

4 1989 Revision MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

METHADYL ACETATE METHANDIENONE METHANDRIOL METHAQUALONE METHENOLONE METHYLAMINOREX METHYLAMPHETAMINE METHYLDESORPHINE METHYLDIHYDROMORPHINE (6-methyldihydromorphine) METHYLPHENIDATE METHYLPHENOBARBITONE METHYLTESTOSTERONE METHYPRYLONE METOPON METRIBOLONE MIBOLERONE MIDAZOLAM MORPHERIDINE MORPHINE MORPHINE METHOBROMIDE, morphine n-oxide and other pentavalent nitrogen morphine derivatives MYROPHINE

NANDROLONE N, N-DIETHYLTRYPTAMINE N, N-DIMETHYLTRYPTAMINE N-ETHYLAMPHETAMINE N-HYDROXYTENAMPHETAMINE (N-hydroxy MDA) NICOCODINE NICODICODINE (6-nicotinoyldihydrocodeine) NICOMORPHINE (3,6-dinicotinoylmorphine) NIMETAZEPAM NITRAZEPAM NORACYMETHADOL NORBOLETONE NORCLOSTEBOL NORCODEINE NORDIAZEPAM NORETHANDROLONE NORLEVORPHANOL NORMETHADONE NORMORPHINE NORPIPANONE

OPIUM whether raw, prepared or medicinal OVANDROTONE OXABOLONE OXANDROLONE OXAZEPAM

1989 Revision 5 MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

OXAZOLAM OXYCODONE OXYMESTERONE OXYMETHLONE OXYMORPHONE

PEMOLINE PENTAZOCINE PETHIDINE PHENADOXONE PHENAMPROMIDE PHENAZOCINE PHENCYCLIDINE PHENDIMETRAZINE PHENMETRAZINE PHENOMORPHAN PHENOPERIDINE PHENTERMINE PHOLCODINE PIMINODINE PINAZEPAM PIPRADROL PIRITRAMIDE POPPY-STRAW and concentrate of poppy-straw PRASTERONE PRAZEPAM PROHEPTAZINE PROPERIDINE (1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester) PROPETANDROL PROPIRAM PROPYLHEXEDRINE PSILOCIN PYROVALERONE

QUINBOLONE

RACEMETHORPHAN RACEMORAMIDE RACEMORPHAN ROLYCYCLIDINE ROXIBOLONE

SILANDRONE SOMATOTROPIN SOMATREM SOMATROPIN STANOLONE STANOZOLOL

6 1989 Revision MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

STENBOLONE SUFENTANIL

TEMAZEPAM TENOCYCLIDINE TESTOSTERONE TETRAZEPAM THEBACON THEBAINE THIOMESTERONE TILIDATE TRENBOLONE TRIAZOLAM TRIMEPERIDINE

4-BROMO-2,5-DIMETHOXY-α-METHYLPHENETHYLAMINE 4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE 4-CYANO-1-METHYL-4-PHENYLPIPERDINE 2,5 -DIMETHOXY-α,4-DIMETHYLPHENETHYLAMINE 2-METHYL-3-MORPHOLINO-1,1- DIPHENYLPROPANECARBOXYLIC ACID 1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID 4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER (norpethidine)

(b) any 5,5 disubstituted barbituric acid;

(c) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(d) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, an N- alkylphenethylamine, α-methylphenethylamine, and N- Alkyl α-methylphenethylamine, or an N-alkyl α- ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.

1989 Revision 7 MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say —

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(f) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say —

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of a N-oxide or of a quaternary base;

8 1989 Revision MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001

(g) [any drug falling within the following generic definition:], that is to say, any compound (not being Trilostane or a compound for the time being specified in sub-paragraph

(a)) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways —

(i) by further substitution at position 17 by a methyl or ethyl group;

(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16 but at no other positions;

(iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv) by fusion of ring A with a heterocyclic system.

2. Any stereoisomeric form of a substance for the time being

3. specified in paragraph 1 not being dextromethorphan or dextrorphan.

4. paragraph 1 or 2.

one hydroxyl function is available, both an ester and an ether) or a substance specified in the paragraphs 1(f)(i) to (iv).

5. Any salt of a substance for the time being specified in any of

6. paragraphs 1 to 3.

product for the time being specified in any of paragraphs 1 to 4.

Made this 1st day of August, 2001

Minister of Health and Family Services

1989 Revision 9